FOXP2 and schizophrenia: In conclusion, we provide a plausible explanation of the reduction in GM density observed in schizophrenia patients through differential expression of FOXP2. Our results supported the previous view that posited a link between the genetic variation of FOXP2 and brain morphometry in schizophrenia.